The US medical tourism market is still a burgeoning industry. As such, its development will be dictated by a variety of market factors and the reactions of a variety of market sectors.
1. Quality. One issue facing the US medical tourism industry is one of perception – the US consumer perception of the quality of overseas providers. While the high quality of overseas providers is well-known to industry watchers, the question remains of how US consumers will take to traveling to what they may otherwise consider a “third world” or “developing” nation for complex surgery. Accreditation by respected organizations, such as the Joint Commission, may help convince consumers of the quality of providers, but will accreditation satisfy the US consumer? What are the standards US consumers can look to? Are there reliable sources of information? What are overseas providers doing to education the US consumer? How will US consumers react to the reporting of overseas medical “horror stories”?
2. Employer Participation. Unlike much of the world, US employers play a significant role in the choices available to US consumers of health care. Employers have provided preferred provider networks for decades. Accordingly, employer participation in the medical tourism industry would provide a boost to the medical tourism industry. But the initial efforts of some employers have produced strong reactions from labor unions. Will employers eager to save money of health benefits push to make medical tourism a part of the benefits they offer? Will medical tourism become a negotiating point under labor contracts? To what extent will employers investigate overseas providers, and how do they ensure their employees receive quality services? Will employers incorporate medical tourism into their self-insured health plans?
3. Third-Party Payer Participation. Medical tourism will grow more rapidly as an industry if third-party payers are willing to participate. While government payers are unlikely to include medical tourism in their reimbursement policies, private payers have already begun to offer products that include a medical tourism component. Will the lack of Medicare/Medicaid participation limit the growth of the medical tourism industry significantly? How have insurance companies assessed the quality of overseas providers? What level of incentives will be necessary to generate beneficiary participation?
4. Liability and Malpractice. While medical tourism offers tremendous cost savings, it does come with increased risk, to consumers and payers. Individuals receiving medical care overseas would need to resort to the legal process available in the foreign country should anything go wrong. This may mean limited and difficult to obtain remedies. This, in turn, could lead to pressure on insurers and employers. What are the liability risks for insurers and employers? Can insurers and employers take steps to shield themselves from liability? Should employers and insurers offer indemnification to assist consumers who receive inappropriate care? Will employees and beneficiaries be willing to waive liability in order to receive lower cost health care?
5. Government Reaction. The Federal government is convening an interagency committee to examine medical tourism, and a West Virginia legislator has proposed legislation to promote medical tourism as a cost savings measure. Are the federal or state governments in a position to help or hinder the medical tourism industry? Can the government “fix” the health industry to relieve the pressure to seek medical treatment elsewhere?
6. US Healthcare Providers. Medical tourism represents competition for US healthcare providers. On the other hand, some US healthcare providers have participated in the operations of overseas providers, such as John’s Hopkins and Harvard. Will US providers embrace medical tourism and seek to create opportunities from medical tourism? Will overseas providers seek access to the US markets by investing in US providers?
All questions and no ideas or answers is simply is frustrating.